New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)

Completed · Phase 3

Conditions studied: Pneumonia, Pneumococcal, Community Acquired Infections, Gram-positive Bacterial Infections

In brief

This study will treat patients who have a community-acquired pneumonia that is due to a specific bacteria (S. pneumoniae)

Key facts

Study ID
NCT00035269
Run by
Pfizer
People needed
230
Starts
2001-12-01
Expected to finish
2003-05-01
Last updated by the study team
2011-04-26

Who can join

Age: 13 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.